These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 33442822)

  • 1. Optimal interpretation of Tc99m PYP in 2020: Avoiding the million-dollar mistake.
    Gerber J; Miller EJ
    J Nucl Cardiol; 2021 Apr; 28(2):503-506. PubMed ID: 33442822
    [No Abstract]   [Full Text] [Related]  

  • 2. A cardiology fellow's take-home points from ASNC's Webinar: Cases in Tc 99m-PYP evaluation of ATTR cardiac amyloidosis - interpretation and reporting.
    Shetty M
    J Nucl Cardiol; 2021 Apr; 28(2):604-609. PubMed ID: 33655447
    [No Abstract]   [Full Text] [Related]  

  • 3. Interpreting technetium-99m pyrophosphate cardiac scans to diagnose transthyretin cardiac amyloidosis: Need for due diligence.
    Butera B; Klingler D; Mccord JK; Ananthasubramaniam K
    J Nucl Cardiol; 2021 Aug; 28(4):1798-1801. PubMed ID: 32390109
    [No Abstract]   [Full Text] [Related]  

  • 4. Nuclear tracers for transthyretin cardiac amyloidosis: time to bone up?
    Ruberg FL; Miller EJ
    Circ Cardiovasc Imaging; 2013 Mar; 6(2):162-4. PubMed ID: 23512778
    [No Abstract]   [Full Text] [Related]  

  • 5. Value of SPECT imaging in patients with TTR-amyloid: ratios are not enough.
    Hussain M; Collier P; Jaber W
    J Nucl Cardiol; 2021 Apr; 28(2):747-749. PubMed ID: 31858425
    [No Abstract]   [Full Text] [Related]  

  • 6. Estimating cancer risk from
    Einstein AJ; Shuryak I; Castaño A; Mintz A; Maurer MS; Bokhari S
    J Nucl Cardiol; 2020 Feb; 27(1):215-224. PubMed ID: 29850972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. (99m)Tc-pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses.
    Bokhari S; Castaño A; Pozniakoff T; Deslisle S; Latif F; Maurer MS
    Circ Cardiovasc Imaging; 2013 Mar; 6(2):195-201. PubMed ID: 23400849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. National patterns in imaging utilization for diagnosis of cardiac amyloidosis: A focus on Tc99m-pyrophosphate scintigraphy.
    Harb SC; Haq M; Flood K; Guerrieri A; Passerell W; Jaber WA; Miller EJ
    J Nucl Cardiol; 2017 Jun; 24(3):1094-1097. PubMed ID: 27016106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. False-Positive
    Schafer EB; Tushak Z; Trankle CR; Rao K; Cartagena LC; Shah KB
    Circ Heart Fail; 2021 Mar; 14(3):e007558. PubMed ID: 33663232
    [No Abstract]   [Full Text] [Related]  

  • 10. Non-invasive detection and differentiation of cardiac amyloidosis using
    Takasone K; Katoh N; Takahashi Y; Abe R; Ezawa N; Yoshinaga T; Yanagisawa S; Yazaki M; Oguchi K; Koyama J; Sekijima Y
    Amyloid; 2020 Dec; 27(4):266-274. PubMed ID: 32722948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of planar with tomographic pyrophosphate scintigraphy for transthyretin cardiac amyloidosis: Perils and pitfalls.
    Asif T; Gomez J; Singh V; Doukky R; Nedeltcheva A; Malhotra S
    J Nucl Cardiol; 2021 Feb; 28(1):104-111. PubMed ID: 32901418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tc-99m-pyrophosphate scintigraphy for the diagnosis of ATTR cardiac amyloidosis: Comparison of quantitative and semi-quantitative approaches.
    Régis C; Harel F; Martineau P; Grégoire J; Abikhzer G; Juneau D; Pelletier-Galarneau M
    J Nucl Cardiol; 2020 Oct; 27(5):1808-1815. PubMed ID: 32476105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transthyretin Cardiac Amyloidosis as Diagnosed by 99mTc-PYP Scanning in Patients with Acute Heart Failure and Preserved Ejection Fraction.
    Lo Presti S; Horvath SA; Mihos CG; Rajadhyaksha C; McCloskey V; Santana O
    Crit Pathw Cardiol; 2019 Dec; 18(4):195-199. PubMed ID: 31725511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Case of Biopsy-Proven Wild-Type ATTR Cardiac Amyloidosis With Abnormal CMR and Negative
    Yabut J; Nadig V; Arora S; Hirsch D; Duvall WL
    Circ Cardiovasc Imaging; 2024 Jan; 17(1):e015734. PubMed ID: 38146653
    [No Abstract]   [Full Text] [Related]  

  • 15. A potential pitfall in the use of
    Murray CSG; Moadel RM; Tauras JM; Zamora E; Travin MI
    J Nucl Cardiol; 2021 Oct; 28(5):2395-2398. PubMed ID: 32449000
    [No Abstract]   [Full Text] [Related]  

  • 16. Diagnostic and prognostic value of Technetium-99m pyrophosphate uptake quantitation for transthyretin cardiac amyloidosis.
    Miller RJH; Cadet S; Mah D; Pournazari P; Chan D; Fine NM; Berman DS; Slomka PJ
    J Nucl Cardiol; 2021 Oct; 28(5):1835-1845. PubMed ID: 33689152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of Commonly Examined Parameters Is a Useful Predictor of Positive
    Marume K; Takashio S; Nishi M; Hirakawa K; Yamamoto M; Hanatani S; Oda S; Utsunomiya D; Shiraishi S; Ueda M; Yamashita T; Sakamoto K; Yamamoto E; Kaikita K; Izumiya Y; Yamashita Y; Ando Y; Tsujita K
    Circ J; 2019 Jul; 83(8):1698-1708. PubMed ID: 31189791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cases from a busy nuclear cardiology laboratory: Potential pitfalls in the interpretation of cardiac scintigraphy for ATTR cardiac amyloidosis.
    Wehbe RM; Kansal P; Holly TA
    J Nucl Cardiol; 2021 Apr; 28(2):653-660. PubMed ID: 32383085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A positive Tc-99m PYP scan in a patient with cardiac sarcoidosis.
    El-Tallawi KC; Parikh R; Nabi F; Maclayton PI; Trachtenberg BH; Al-Mallah M
    J Nucl Cardiol; 2021 Oct; 28(5):2390-2394. PubMed ID: 32445166
    [No Abstract]   [Full Text] [Related]  

  • 20. Can
    Haq M; Pawar S; Berk JL; Miller EJ; Ruberg FL
    JACC Cardiovasc Imaging; 2017 Jun; 10(6):713-714. PubMed ID: 27568122
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.